Dual targeting of G9a and DNMT1 for the treatment of experimental cholangiocarcinoma. Colyn L, Barcena-Varela M, Alvarez-Sola G, Latasa MU, et al. Hepatology 2020 Nov 22. doi: 10.1002/hep.31642.

Read + Share

Amedeo Smart

Independent Medical Education

Colyn L, Barcena-Varela M, Alvarez-Sola G, Latasa MU, et al. Dual targeting of G9a and DNMT1 for the treatment of experimental cholangiocarcinoma. Hepatology 2020 Nov 22. doi: 10.1002/hep.31642.
PMID: 33222246